Your browser doesn't support javascript.
loading
Initiation of retinopathy of prematurity screening examinations in extremely premature infants.
Souverein, Erik A; Siegel, Brent A; Siegel, Lance M; Reid, Mark W; Lee, Thomas C; Nallasamy, Sudha.
Affiliation
  • Souverein EA; Keck School of Medicine of University of Southern California, Los Angeles, California.
  • Siegel BA; University of California Berkeley, Berkeley, California.
  • Siegel LM; Children's Eye Institute, Upland, California; The Vision Center, Children's Hospital Los Angeles, Los Angeles, California.
  • Reid MW; The Vision Center, Children's Hospital Los Angeles, Los Angeles, California.
  • Lee TC; The Vision Center, Children's Hospital Los Angeles, Los Angeles, California; USC Roski Eye Institute, Keck School of Medicine of University of Southern California, Los Angeles, California.
  • Nallasamy S; The Vision Center, Children's Hospital Los Angeles, Los Angeles, California; USC Roski Eye Institute, Keck School of Medicine of University of Southern California, Los Angeles, California. Electronic address: sudha.nallasamy@gmail.com.
J AAPOS ; 28(4): 103956, 2024 Aug.
Article de En | MEDLINE | ID: mdl-38878959
ABSTRACT

PURPOSE:

To determine whether extremely premature infants require screening for retinopathy of prematurity (ROP) if <31 weeks' postmenstrual age (PMA).

METHODS:

The medical records of infants born in community hospital settings at <31 weeks' gestational age (GA) were reviewed retrospectively. Prevalence and progression of ROP in infants born at <24 weeks' GA were compared with infants born at 24-30 weeks' GA.

RESULTS:

A total of 2,061 records were reviewed 1,969 infants were born at 24-30 weeks' GA; 92, at <24 weeks. Infants born <24 weeks' GA were more likely to develop pre-plus and plus disease or require treatment than infants born 24-30 weeks' GA (P < 0.0001) and did so earlier (P = 0.0001). Eight infants developed pre-plus or greater ROP <31 weeks' PMA; 6 were born <24 weeks' GA. Three infants developed plus disease or required treatment <31 weeks' PMA, the earliest at 27 and 3/7 weeks.

CONCLUSIONS:

Clinicians should consider initiating ROP screening examinations before 31 weeks' PMA, particularly for infants born <24 weeks' GA and those with lower birth weights.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rétinopathie du prématuré / Âge gestationnel / Dépistage néonatal / Très grand prématuré Limites: Female / Humans / Male / Newborn Langue: En Journal: J AAPOS Sujet du journal: OFTALMOLOGIA / PEDIATRIA Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rétinopathie du prématuré / Âge gestationnel / Dépistage néonatal / Très grand prématuré Limites: Female / Humans / Male / Newborn Langue: En Journal: J AAPOS Sujet du journal: OFTALMOLOGIA / PEDIATRIA Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique